The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Getty Properties Corp. v. Parmar
Represented Getty Petroleum Marketing Inc. in a case where a franchisee of the client was terminated he began using the Getty name in connection with more
Simultaneous roll-up/combination of nine companies and initial public offering to form an NYSE-listed public company
Represented principal founding company and sponsor of the roll-up/combination of nine private companies and simultaneous initial public offering and more
Rail agreement between two public transportation systems
Representing a regional public transportation authority in what will be a rail agreement between two public transportation systems. more
Environmental services for largest trade organization in the home furnishings industry
Serves as national environmental counsel to world's largest and most influential trade organization serving the home furnishings industry, where we more